Cerulean Pharma reported $30.88M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US 15.9M 9.98M
Agile Therapeutics AGRX:US $ 2.74M 6.53M
Arrowhead Research ARWR:US $ 453.93M 1.66M
Bayer BAYN:GR € 37437M 4417M
Biocept BIOC:US $ 37.03M 0.45M
Brainstorm Cell Therapeutics BCLI:US $ 14.49M 4.86M
Cerulean Pharma CERU:US $ 30.88M 7.88M
Immunogen IMGN:US $ 249.83M 56.64M
Macrogenics MGNX:US $ 178.21M 61.4M
Nektar Therapeutics NKTR:US $ 458.73M 149.16M
Perrigo Ordinary Shares PRGO:US $ 5104.5M 47.2M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
YTE INCY:US $ 4085.06M 221.99M